Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa double-blind randomized trial of AZD8848 in allergic asthma
2009-013705-34Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in allergic asthma comparing AZD8848 with Placebo (2 arms). Primary endpoints: Efficacy on late asthmatic response, Tolerability of AZD8848 and 1 more. Started Jul 2009; status: completed.
02
Drugs
azd-8848
03
Conditions
allergic asthma
Beyond the preview
Go deeper on 2009-013705-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013705-34.